Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity.

about

Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity.

Item

http://www.wikidata.org/entity/Q41124277

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of Prophylactic Use of ...... Drugs Induced Hepatotoxicity.

@en

type

Item

label

Effect of Prophylactic Use of ...... Drugs Induced Hepatotoxicity.

@en

prefLabel

Effect of Prophylactic Use of ...... Drugs Induced Hepatotoxicity.

@en

P1476

Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity

@en

P2093

Deog Kyeom Kim

http://www.w3.org/2001/XMLSchema#string

Eunyoung Heo

http://www.w3.org/2001/XMLSchema#string

Ju-Hee Park

http://www.w3.org/2001/XMLSchema#string

Jung-Kyu Lee

http://www.w3.org/2001/XMLSchema#string

So Hee Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

An official ATS statement: hepatotoxicity of antituberculosis therapy.

"Silymarin", a promising pharmacological agent for treatment of diseases

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.

Early monitoring for detection of antituberculous drug-induced hepatotoxicity

Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

A prospective nationwide study of drug-induced liver injury in Korea.

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.

Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.

P304

265-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4046/TRD.2017.80.3.265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heesun Chung

P577

2017-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28747959

http://www.w3.org/2001/XMLSchema#string

P921

hepatotoxicity

P932

5526953

http://www.w3.org/2001/XMLSchema#string